Autris (OTCMKTS:AUTR) Gets a Re-Pump
Autris (OTCMKTS:AUTR) fell victim to a $400 thousand pump back in Q4 of 2014. Some newsletters sent out a few emails, and David Moore from Rising Stock Advisor set up a landing page. He said that the stock could ‘take Wall Street by storm.’ He was catastrophically wrong.
$400 thousand is no small amount for a penny stock promotion, but despite this, the one for AUTR simply didn’t work. The pump failed to attract significant volumes and although the ticker went through a several wild swings in both directions, once the pumpers went away, interest all but disappeared. Slowly but surely, the stock slid down from more than $0.20 per share in January all the way to $0.06 at the beginning of the month.
Yesterday, however, it sprang back to life. In a matter of six and a half hours, investors traded a record-breaking 2.9 million shares which resulted in a dollar volume of more than $200 thousand. Unfortunately, the ones who put their money on the line are probably pretty disappointed. AUTR opened the day with a massive 50% gap up at $0.09 and it tried to make a run for the higher end of the charts. A few minutes after the opening bell, it hit and intraday high of $0.094, but then, it stumbled and went back where it came from. The closing bell stopped AUTR at $0.06 (just 0.17% in the green). So, the people who jumped in yesterday are most likely pretty disappointed, but why did they put their money on the line in the first place?
Because AUTR is targeted by another promotion. There are no new landing pages, but we did receive some email alerts from Penny Stock Professor and their affiliated newsletters who pocketed a $25 thousand compensation.
Willingly or not, the company lent a helping hand as well. A few minutes before the opening bell (and a few hours after the emails started hitting our inbox), AUTR announced that it has signed a master international distribution agreement with an entity called The Doctor’s Touch. The agreement, the management team said, will help AUTR promote their products through their new partners’ numerous franchises.
Hopefully, it will indeed have a significant impact on the company’s financial statements because the latest 10-Q shows that the sales figures aren’t exactly consistent. The revenues for the nine months ended December 31, 2014, for example, are about 40% down from the ones registered during the same period of 2013.
That said, we should probably point out that, by the low standards set by other promoted OTC companies, AUTR‘s latest 10-Q isn’t actually that bad. Here’s a summary of the figures recorded during the fourth calendar quarter of 2014:
- cash: $96 thousand
- current assets: $190 thousand
- current liabilities: $353 thousand
- quarterly revenues: $299 thousand
- quarterly net loss: $1,500
As you can see, there isn’t a whole lot of cash and the liabilities are a bit steep. Nevertheless, the products are on the market and the company just about managed to break even for the first time since going public in the fourth quarter of 2013. But does this mean that the risk is worth it?
Well, you’ve already seen what the performance is when the pumpers are involved. All you need to do is decide whether anything could be different this time around.
